MedPath

Effect of ezetimibe in hypercholesterolemic patient with glucose tolerance

Not Applicable
Conditions
Dyslipidemia
Registration Number
JPRN-UMIN000004091
Lead Sponsor
Chigasaki Municipal Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

1)HbA1c>=9% 2)Patients with a history of hypersensitivity to any ingredient of ezetimibe tablets 3)Severe renal or hepatic disease 4)Having prior myocardial infarction or stroke 5)Patients with secondary hyperlipidemia or drug-associated hyperlipidemia 6)Patients who are pregnant or nursing mothers, patients who may be pregnant, or patients who want to become pregnant during participation in the study. 7)Familial hypercholesterolemia 8)Other patients deemed not appropriate for study entry by the investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The change of liipd levels(TC,TG,HDL-C,LDL-C,RLP-C)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath